Exelixis (EXEL) Gross Profit (2012 - 2026)
Exelixis' Gross Profit was $608.03 million in Q2 2027, up 10.8% from $548.79 million a year earlier and up 2.9% from the prior quarter.
Powered by 
Analysis
Exelixis (EXEL) Gross Profit (2012 - 2026) Analysis & Trends
On a trailing twelve-month basis, Exelixis' Gross Profit was $2.35 billion through Jul 3, 2026, up 9.1% year-over-year; for FY2026, it came in at $2.24 billion, up 6.9% from FY2025.
- Gross Profit shows a five-year compound annual growth rate of 10.1% (FY2021 to FY2026).
- In earlier years, Gross Profit was $2.09 billion in FY2025, $1.76 billion in FY2023 (+13.2%) and $1.55 billion in FY2022 (+12.4%).
- The Q2 2027 figure marks the highest quarterly Gross Profit since Q2 2025.
- Compared with a year earlier, Gross Profit has increased for four straight quarters, with growth averaging 9.6% over the last six quarters.
- Per Business Quant data, EXEL's Gross Profit in the three quarters before Q2 2027 was $590.86 million (Q1 2027), $572.18 million (Q4 2026) and $579.18 million (Q3 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Exelixis | 14.54 Bn | 10.87 Bn | 608.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 608.03 Mn |
| Apr 3, 2026 | 590.86 Mn |
| Jan 2, 2026 | 572.18 Mn |
| Oct 3, 2025 | 579.18 Mn |
| Jul 4, 2025 | 548.79 Mn |
| Apr 4, 2025 | 536.28 Mn |
| Jan 3, 2025 | 546.79 Mn |
| Sep 27, 2024 | 522.21 Mn |
| Jun 28, 2024 | 619.51 Mn |
| Mar 29, 2024 | 403.97 Mn |
| Dec 29, 2023 | 457.90 Mn |
| Sep 29, 2023 | 453.15 Mn |
| Jun 30, 2023 | 452.14 Mn |
| Mar 31, 2023 | 394.47 Mn |
| Dec 30, 2022 | 408.00 Mn |
| Sep 30, 2022 | 396.43 Mn |
| Jul 1, 2022 | 405.95 Mn |
| Apr 1, 2022 | 342.78 Mn |
| Oct 1, 2021 | 316.55 Mn |
| Jul 2, 2021 | 370.29 Mn |
API Access
Exelixis Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=EXEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "EXEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=EXEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();